Analysis of the expression directed by two HTLV-I promoters in transgenic mice

Journal of NeuroVirology

Volumn 2, Issue 5, 1996, Pages 336-344

  Coscoy, Laurent ^a   Gonzalez Dunia, Daniel ^a   Chirinian Syan, Sylvie ^a   Brahic, Michel ^a   Ozden, Simona ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

ATL; CNS; HTLV I LTR; TSP HAM; galactosidase

Indexed keywords

BETA GALACTOSIDASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CHOROID PLEXUS; EPENDYMA CELL; HUMAN T CELL LEUKEMIA VIRUS 1; LONG TERMINAL REPEAT; MOUSE; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; VIRUS EXPRESSION;

ANIMALIA; HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; MUS MUSCULUS;

EID: 0029852551     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289609146898     Document Type: Article

References (40)

1. Bhigjee AI, Wiley CA, Wachsman W, Amenomori T, Pirie D, Bill PLA, Windsor I (1991). HTLV-I associated myelopathy: Clinicopathologic correlation with localization of provirus to spinal cord. Neurology 41: 1990-1992.
2. Bonnerot C, Rocancourt D, Briand P, Grimber G, Nicolas JF (1987). A β-galactosidase hybrid protein targeted to nuclei as a marker for developmental studies. Proc Natl Acad Sci USA 84: 6795-6799.
3. Bieberich C, King C, Tinkle B, Jay G (1993). A Transgenic model of transactivation by the Tax Protein of HTLV-I. Virology 196: 309-318.
4. Brahic M, Ozden S (1992). Simultaneous detection of cellular RNA and proteins. In: In situ Hybridization - A practical Approach. RG Wilkinson, (ed). IRL Press: Oxford, pp. 85-104.
5. Caßens S, Ulrich U, Beimling P, Simon D (1994). Inhibition of human T cell leukaemia virus type I long terminal repeat expression by DNA methylation: implications for latency. J Gen Virol 75: 3255-3259.
6. Chomczynski P, Sacchi N (1987). Single-step method of RNA isolation by Acid Guanidinium Thiocyanate-Phenol-Chloroform extraction. Anal Biochem 162: 156-159.
7. Gessain A, Barin E, Vernant JC, Gout O, Maurs L, Calender A, de Thé G (1985). Antibodies to human T-lymphotropic virus type-1 in patients with tropical spastic paraparesis. Lancet ii: 407-410.
8. Gonzalez-Dunia D, Chirinian-Syan S, Brahic M, Ozden S (1992a). Functional analysis of two long terminal repeats from the HTLV-I retrovirus. Gene 116: 151-158.
9. Gonzalez-Dunia D, Grimber G, Briand P, Brachi M, Ozden S (1992b). Tissue expression pattern directed in transgenic mice by the LTR of an HTLV-I provirus isolated from a case of tropical spastic paraparesis. Virology 187: 705-710.
10. Gonzalez-Dunia D, Komurian-Pradel F, Chirinian-Syan S, de Thé G, Brahic M, Ozden S (1993). Comparative analysis of HTLV-I promoter activities reveals no disease-linked pattern of expression. Aids Research and Human Retroviruses 9: 337-341.
11. Graessmann A, Sandberg G, Guhl E, Graessmann M (1994). Methylation of single sites within the herpes simplex virus tk coding region and the simian virus 40 T-antigen intron causes gene inactivation. Mol Cell Biol 14: 2004-2010.
12. Hara H, Morita M, Iwaki T, Hatae T, Itoyama Y, Kitamoto T, Akizuki SI, Goto I, Watanabe T (1994). Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor Vβ CDR3 sequences in spinal cord lesions in HTLV-I associated myelopathy/tropical spastic paraparesis. J Exp Med 180: 831-839.
13. Jacobson S, Raine CS, Mingioli ES, McFarlin DE (1988). Isolation of an HTLV-I-like retrovirus from patients with tropical spastic paraparesis. Nature 331: 540-543.
14. Kaplan JE, Osame M, Kubota H, Igata A, Nishitani H, Maeda Y, Khabbaz RF, Janssen RS (1990). The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquired Immune Defic Syndr 3: 1096-1101.
15. Kira T, Itoyama Y, Koyanagi Y, Tateishi J, Kishikawa M, Akizuki S, Kobayashi I, Toki N, Sueishi K, Sato H, Sakaki Y, Yamamoto B, Goto I (1992). Presence of HTLV-I proviral DNA in central nervous system of patients with HTLV-I associated myelopathy. Ann Neurol 31: 39-45.
16. Kitamura T, Takano M, Hoshino H, Shimotohno K, Shimoyama M, Miwa M, Takaku F, Sugimura T (1985). Methylation pattern of human T-cell leukemia in vivo and in vitro: pX and LRT regions are hypomethylated in vivo, Int J Cancer 35: 629-635.
17. Komurian-Pradel F, Pelloquin F, de Thé G (1991). In vivo genomic variability of human T-cell leukemia virus type I depends more upon geography than upon pathologies. J Virol 65: 3770-3778.
18. Kubota R, Umehara F, Izumo S, Ijishi S, Matsumuro K, Yashiki S, Fujiyoshi T, Sonoda S, Osame M (1994). HTLV-I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I associated myelopathy. J Neuroimmunol 53: 23-29.
19. Lehky TJ, Fox CH, Koenig S, Levin MC, Flerlage N, Izumo S, Sato E, Raine CS, Osame M, Jacobson S (1995). Detection of human T-lymphotropic virus type I (HTLV-I) Tax RNA in the central nervous system of HTLV-I-associated . myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol 37: 167-175.
20. Leon-Monzon M, Illa I, Dalakas MC (1994). Polymyositis in patients infected with human T-cell leukemia virus type I: the role of the virus in the cause of the disease. Annals of neurology 36: 643-649.
21. Mochizuki M, Watanabe T, Yamaguchi K (1992). HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res 83: 236-239.
22. Morgan O, Rodgers-Johnson P, Mora C, Char G (1989). HTLV-I and polymyositis in Jamaica. Lancet ii: 1184-1186.
23. Murphy EL, Hanchord B, Figueroa JP, Gibb WN, Lofters WS, Campbell M, Goedert JJ, Blattner WA (1989). Modelling the risk of ATL in persons infected with HTLV-I. Int J Cancer 43: 250.
24. Nagy K, Weiss RA, Clapham P, Cheigsong-Popov R (1984). Biological properties of human T-cell leukaemia virus envelope antigens. In: Human T-cell Leukaemia/Lymphoma viruses. RC Gallo, M Essex, L Gross, (ed). Cold Spring Harbor Laboratory: Cold Spring Harbor, NY, pp. 121-131.
25. Nishioka K, Maruyama I, Sato K, Kitajama I, Nakajima Y, Osame M (1989). Chronic inflammatory arthropathy associated with HTLV-I. Lancet i: 441.
26. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M (1986). HTLV-I associated myelopathy, a new clinical entity. Lancet i: 1031-1032.
27. Ottaviano YL, Issa JP, Pari FF, Smith HS, Baylin SB, Davidson NE (1994). Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res 54: 2552-2555.
28. Ozden S, Aubert C, Gonzalez-Dunia D, Brahic M (1991). In situ analysis of proteolipid protein gene transcripts during persistent Theiler's virus infection. J Histochem Cytochem 39: 1305-1309.
29. Paquette Y, Kay DG, Rassart E, Robitaille Y, Jolicoeur P (1990). Substituion of the U3 long terminal repeat region of the neurotropic Cas-Br-E retrovirus affects its disease-inducing potential. J Virol 64: 3742-3752.
30. Poiesz BJ, Ruscetti FW, Gadzar AF, Bunn PA, Minna JD, Gallo RC (1980). Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T cell lymphoma. Proc Natl Acad Sci USA 77: 7415-7419.
31. Rassart E, Paquette Y, Jolicoeur P (1988). Inability of kaplan radiation leukemia virus to replicate on mouse fibroblast is conferred by its long terminal repeat. J Virol 62: 3840-3848.
32. Richardson JH, Edwards AJ, Cruickshank JK, Rudge P, Dalgleish AG (1990). In vivo cellular tropism of Human T-cell leukemia virus tupe I. J Virol 64: 5682-5687.
33. Saggioro D, Forino M, Chieco-Bianchi L (1991). Transcriptional block of HTLV-I LTR sequence-specific methylation. Virology 182: 68-75.
34. Saggioro D, Panozzo M, Chieco-Bianchi L (1990). Human T-lymphotropic virus type I transcription regulation by methylation. Cancer Res 50: 4968-4973.
35. Sanes JR, Rubenstein JLR, Nicolas JF (1986). Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. Embo J 5: 3133-3142.
36. Straus W (1982). Imidazole increases the sensitivity of the cytochemical reaction for peroxidase with diaminobenzidine at a neutral pH. J Histochem Cytochem 30: 491-493.
37. Sugimoto M, Nakashima H, Watanabe S, Uyama E, Tanaka F, Ando M, Araki S, Kawasaki S (1987). T lymphocytes alveolitis in HTLV-I associated myelopathy. Lancet ii: 1220.
38. Terada K, Katamine S, Eguchi K, Moriuchi R, Kita M, Shimada H, Yamashita I, Iwata K, Tsuji Y, Nagataki S, Miyamoto T (1994). Prevalence of serum and salivary antibodies to HTLV-I in Sjögren's syndrome. The Lancet 344: 1116-1119.
39. Vernant JC, Buisson G, Magdeleine J, De Thore J, Jouannelle A, Neisson-Vernant C, Monplaisir N (1988). T-lymphocyte alveolitis, tropical spastic paraparesis, and Sjögren syndrome. Lancet i: 177.
40. Yoshida B, Miyoshi I, Hinuma Y (1982). Isolation and characterization of retrovirus from cell lines of human adult T cell leukaemia and its implication in the disease. Proc Natl Acad Sci USA 79: 2031-2035.